Analysis | Metabolite Name | Measured Value | Units | Sample | Treatment |
---|---|---|---|---|---|
Reversed phase NEGATIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | 0.5265 | Peak area | Feces | Saline |
Reversed phase NEGATIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | 0.5918 | Peak area | Feces | Saline |
Reversed phase NEGATIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | 0.6002 | Peak area | Feces | Saline |
Reversed phase NEGATIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | 0.7468 | Peak area | Feces | Angiotensin II |
Reversed phase NEGATIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | 0.7888 | Peak area | Feces | Saline |
Reversed phase NEGATIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | 0.8319 | Peak area | Feces | Angiotensin II |
Reversed phase NEGATIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | 0.8668 | Peak area | Feces | Angiotensin II |
Reversed phase NEGATIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | 0.8700 | Peak area | Feces | Angiotensin II |
Reversed phase NEGATIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | 0.9117 | Peak area | Feces | Saline |
Reversed phase NEGATIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | 0.9335 | Peak area | Feces | Saline |
Reversed phase NEGATIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | 0.9550 | Peak area | Feces | Angiotensin II |
Reversed phase NEGATIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | 0.9873 | Peak area | Feces | Angiotensin II |
Reversed phase NEGATIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | 1.0127 | Peak area | Feces | Saline |
Reversed phase NEGATIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | 1.0266 | Peak area | Feces | Angiotensin II |
Reversed phase NEGATIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | 1.1190 | Peak area | Feces | Angiotensin II |
Reversed phase NEGATIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | 1.1678 | Peak area | Feces | Saline |
Reversed phase NEGATIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | 1.2923 | Peak area | Feces | Angiotensin II |
Reversed phase NEGATIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | 1.3174 | Peak area | Feces | Angiotensin II |
Reversed phase NEGATIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | 1.3798 | Peak area | Feces | Saline |
Reversed phase NEGATIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | 1.3984 | Peak area | Feces | Saline |
Reversed phase NEGATIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | 1.4070 | Peak area | Feces | Saline |
Reversed phase NEGATIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | 1.5309 | Peak area | Feces | Angiotensin II |
Reversed phase NEGATIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | 1.7288 | Peak area | Feces | Angiotensin II |
Reversed phase NEGATIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | 2.3750 | Peak area | Feces | Saline |